Click to Share
 
 
  1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Reporter Account

genome News

  + XML/RSS  



By Cambridge Healthtech Institute
Delegates now have the option to choose from 3 moderated breakout discussion groups in the exhibit hall at this conference that is set for February 21-23, Moscone North Convention Center, San Francisco, CA (part of CHI's Molecular Med TRI-CON 2012).

By Cambridge Healthtech Institute
Dr. Quackenbush will present in the translating biomarker driven cancer treatments into practice session.

By Cambridge Healthtech Institute
Christopher P. Austin, M.D., Scientific Director, NIH Center for Translational Therapeutics, will deliver the keynote presentation at CHI’s Predictive Functional Human Tissue Models conference scheduled on November 17-18, 2011, Boston, MA.

By Cambridge Healthtech Institute
Hear talks on NGS Data Management, and the impact of Sequencing on personalized medicine. This conference will take place on September 26-28, 2011 in Providence, RI. Early registration discounts will be offered until July 29.

All Press Releases

By Cambridge Healthtech Institute
Delegates now have the option to choose from 3 moderated breakout discussion groups in the exhibit hall at this conference that is set for February 21-23, Moscone North Convention Center, San Francisco, CA (part of CHI's Molecular Med TRI-CON 2012).

By Cambridge Healthtech Institute
Dr. Quackenbush will present in the translating biomarker driven cancer treatments into practice session.

By Janine Holley
NGS Leaders community to host industry discussion on key challenge of next-generation sequencing data

By Cambridge Healthtech Institute
Navigating the Future of Genomic Technologies. March 5-8, 2012 at the Hilton San Diego Resort

By Cambridge Healthtech Institute
Christopher P. Austin, M.D., Scientific Director, NIH Center for Translational Therapeutics, will deliver the keynote presentation at CHI’s Predictive Functional Human Tissue Models conference scheduled on November 17-18, 2011, Boston, MA.

By Genome BC
Technology development in the life sciences sector received a much-needed boost with the announcement of five projects funded through Genome BC’s Proof of Concept (POC) Program. The program promises close to $9M to accelerate...

By Cambridge Healthtech Institute
Hear talks on NGS Data Management, and the impact of Sequencing on personalized medicine. This conference will take place on September 26-28, 2011 in Providence, RI. Early registration discounts will be offered until July 29.

By Johan Poole-Johnson
Sengenics today announced the introduction of a new microarray based genetic diagnostics test into Asia. The microarray used for the test was designed by Oxford Gene Technology (OGT), UK in conjunction with Emory Genetics, USA.

By Genome British Columbia
Canadian scientists are now part of an International team compiling an enormous bank of resources for research into the functions of all known genes.

By kdm communications ltd
Sigma® Life Science and King's College London co-developing miRNA Target Identification Technology

By Genome British Columbia
“Rusts,” a group of fungi that attack and damage plants and trees, cost the international agriculture and forestry sectors billions of dollars in lost revenue every year, with an estimated loss of $200 million a year due to the destruction of...

By Genome BC
Scientists have set a new standard for studying outbreaks of infectious disease by combining advanced genomics with a detailed map of the social relationships between cases to investigate a recent outbreak of tuberculosis in a BC community.

By Second Genome, Inc.
We are pleased to announce that we are changing our company name from PhyloTech to Second Genome.

By Alan & Priscilla Oppenheimer Foundation
The Alan and Priscilla Oppenheimer Foundation announced today that, in collaboration with the Personal Genome Project (PGP), it has begun the process of sequencing the first full human genome in the next major phase of that project, the PGP-1K.

By Cook & Schmid
Uncovering mutations found in deadly transmissible cancer could help conservation efforts

By Cambridge Healthtech Institute
Second-Generation Applications to Third Generation Progress

By Doctor's P.R.
Steve Sommer, M.D., Ph.D., president and founder of MEDomics LLC announces new test for mitochondrial diseases.

By Elsie Johnson
Knight Investments LLC recently supported the ARS Scientist successful sequencing of the parasite genome that is invading and killing local honey bees, in an effort to help solve the problems with pollination.

By Mania Public Relations
20 individuals to be among first in history to be fully sequenced





  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Service
  5. Copyright Notice
  6. About
  7. Advertise
Like PRLog?
2.8K1.1K1.1K
Click to Share